Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$40.97 - $43.33 $340,051 - $359,639
-8,300 Reduced 1.43%
571,100 $24.2 Million
Q4 2023

Feb 13, 2024

SELL
$32.77 - $42.31 $308,038 - $397,714
-9,400 Reduced 1.6%
579,400 $24.2 Million
Q3 2023

Nov 14, 2023

SELL
$35.46 - $40.13 $216,306 - $244,793
-6,100 Reduced 1.03%
588,800 $22.2 Million
Q2 2023

Aug 11, 2023

SELL
$24.24 - $40.97 $109,080 - $184,365
-4,500 Reduced 0.75%
594,900 $22.6 Million
Q1 2023

May 12, 2023

SELL
$23.0 - $31.59 $285,200 - $391,716
-12,400 Reduced 2.03%
599,400 $14.6 Million
Q4 2022

Feb 13, 2023

SELL
$27.6 - $32.99 $968,760 - $1.16 Million
-35,100 Reduced 5.43%
611,800 $17.8 Million
Q3 2022

Nov 14, 2022

SELL
$28.74 - $39.9 $1.07 Million - $1.49 Million
-37,400 Reduced 5.47%
646,900 $19.4 Million
Q2 2022

Aug 12, 2022

BUY
$35.0 - $43.59 $210,000 - $261,540
6,000 Added 0.88%
684,300 $24.7 Million
Q1 2022

May 13, 2022

SELL
$43.12 - $50.3 $763,224 - $890,310
-17,700 Reduced 2.54%
678,300 $29.3 Million
Q4 2021

Feb 11, 2022

SELL
$47.6 - $65.0 $1.17 Million - $1.59 Million
-24,500 Reduced 3.4%
696,000 $34.9 Million
Q3 2021

Nov 12, 2021

SELL
$62.34 - $73.38 $1.05 Million - $1.24 Million
-16,900 Reduced 2.29%
720,500 $45.8 Million
Q2 2021

Aug 13, 2021

SELL
$70.26 - $76.64 $1.1 Million - $1.2 Million
-15,700 Reduced 2.08%
737,400 $53.1 Million
Q1 2021

May 13, 2021

SELL
$70.48 - $79.95 $2.26 Million - $2.56 Million
-32,000 Reduced 4.08%
753,100 $55.5 Million
Q4 2020

Feb 10, 2021

BUY
$54.4 - $73.42 $897,600 - $1.21 Million
16,500 Added 2.15%
785,100 $57.6 Million
Q3 2020

Nov 13, 2020

BUY
$54.41 - $68.2 $1.9 Million - $2.39 Million
35,000 Added 4.77%
768,600 $42.2 Million
Q2 2020

Aug 13, 2020

BUY
$61.66 - $70.16 $4.17 Million - $4.74 Million
67,600 Added 10.15%
733,600 $48.8 Million
Q1 2020

May 14, 2020

BUY
$59.35 - $88.73 $2.94 Million - $4.4 Million
49,600 Added 8.05%
666,000 $40.8 Million
Q4 2019

Feb 13, 2020

BUY
$74.18 - $97.92 $2.57 Million - $3.4 Million
34,700 Added 5.97%
616,400 $54.2 Million
Q3 2019

Nov 13, 2019

BUY
$75.36 - $86.57 $2.17 Million - $2.49 Million
28,736 Added 5.2%
581,700 $43.9 Million
Q2 2019

Aug 12, 2019

BUY
$83.92 - $108.88 $10.6 Million - $13.7 Million
126,164 Added 29.56%
552,964 $47.2 Million
Q1 2019

May 14, 2019

BUY
$85.97 - $108.09 $4 Million - $5.03 Million
46,500 Added 12.23%
426,800 $46.1 Million
Q4 2018

Feb 13, 2019

BUY
$78.25 - $107.92 $29.8 Million - $41 Million
380,300 New
380,300 $32.2 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.